ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. WEJMMS. 2024;2(6):11-20. Accessed January 31, 2026. https://westerneuropeanstudies.com/index.php/3/article/view/1131